Why AnteoTech, BrainChip, City Chic, and ResMed shares are charging higher

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a decline. At the …

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a decline. At the time of writing, the benchmark index is down 1% to 7,399.7 points.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are charging higher:

a man sits at his computer screen scrolling with his fingers with a satisfied smile on his face as though he is very content with the news he is receiving.

Image source: Getty Images

AnteoTech Ltd (ASX: ADO)

The AnteoTech share price is up 18% to 30 cents. Investors have been buying this medical device company's shares amid reports the company is planning to ramp up production of its rapid antigen test now that the device is in the final stages of TGA approval. Given supply shortages in Australia, this bodes well for the company's sales in 2022.

BrainChip Holdings Ltd (ASX: BRN)

The BrainChip share price has jumped over 16% to $1.63. This morning the artificial intelligence technology company announced that it has submitted a capital call notice to LDA Capital. It expects to bring in $20 million of funds from the issue of up to 15 million shares. These funds will be used to support its commercialisation strategy.

City Chic Collective Ltd (ASX: CCX)

The City Chic share price has surged 12% higher to $5.01. This follows the release of a trading update by the plus sized fashion retailer. City Chic revealed that it expects to report first half sales growth of 49.8% but flat earnings for the period. However, investors appear to be looking beyond the latter given that it was caused by one-off COVID impacts to margins.

ResMed Inc (ASX: RMD)

The ResMed share price is up 4% to $35.05. This gain may have been driven by news this week that rival Philips is increasing its device recall from 3 to 4 million CPAP devices to over 5 million devices. This bodes well for ResMed and could keep Philips out of the market for longer than first anticipated.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

A woman looks shocked as she drinks a coffee while reading the paper.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a brutal day on the markets this Thursday.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Gainers

Which were the best-performing ASX 200 shares in September?

These shares didn't let a falling market stop them from racing higher last month.

Read more »

Multi-ethnic people looking at a camera in a public place and screaming, shouting, and feeling overjoyed.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a strong hump day on the ASX today.

Read more »

Ten smiling business people wave to the camera after receiving some winning company news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a wild, but ultimately positive, Tuesday for investors.

Read more »

Rocket going up above mountains, symbolising a record high.
Share Gainers

Invested $5,000 in Dateline shares a week ago? Here's how much you'd have now

It's been a huge week for Dateline shares.

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy start to the week's trading today.

Read more »

A woman's hand draws a stylised 'Top Ten' on a projected surface.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a sour end to the trading week for investors this Friday.

Read more »

Drone flying in the sky.
Share Gainers

EOS shares jump 7% as ASX 200 falls. Could $15 be next?

Could this ASX defence stock have much further to run?

Read more »